House Study Bill 216 



                                       SENATE/HOUSE FILE       
                                       BY  (PROPOSED GOVERNOR'S
                                            OFFICE OF DRUG CONTROL
                                            POLICY BILL)


    Passed Senate, Date               Passed House,  Date             
    Vote:  Ayes        Nays           Vote:  Ayes        Nays         
                 Approved                            

                                      A BILL FOR

  1 An Act relating to the sale of a pseudoephedrine product by a
  2    pharmacy or retailer, and providing penalties and contingent
  3    applicability.
  4 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
  5 TLSB 1286DP 82
  6 jm/gg/14

PAG LIN



  1  1    Section 1.  Section 124.212, subsection 4, paragraph c,
  1  2 Code 2007, is amended to read as follows:
  1  3    c.  Pseudoephedrine.  A person shall present a
  1  4 government=issued driver's license or other state=issued photo
  1  5 identification card when purchasing a pseudoephedrine product
  1  6 from a pharmacy.  A person shall not purchase more than seven
  1  7 thousand five hundred milligrams of pseudoephedrine, either
  1  8 separately or collectively, within a thirty=day period a
  1  9 quantity of pseudoephedrine in violation of section 124.213
  1 10 from a pharmacy, unless the person has a prescription for a
  1 11 pseudoephedrine product in excess of that quantity.  A
  1 12 pseudoephedrine product not excepted from this schedule shall
  1 13 be sold by a pharmacy as provided in section 124.212A.
  1 14    Sec. 2.  NEW SECTION.  124.212A  PHARMACY PSEUDOEPHEDRINE
  1 15 SALE == RESTRICTIONS == RECORDS == CONTINGENT APPLICABILITY.
  1 16    1.  A pharmacy, an employee of a pharmacy, or a licensed
  1 17 pharmacist shall do the following:
  1 18    a.  Provide for the sale of a pseudoephedrine product in a
  1 19 locked cabinet or behind the sales counter where the public is
  1 20 unable to reach the product and where the public is not
  1 21 permitted.
  1 22    b.  Require the purchaser to present a driver's license or
  1 23 other state=issued photo identification card identifying the
  1 24 purchaser prior to purchasing a pseudoephedrine product.
  1 25    c.  Provide an electronic logbook for purchasers of
  1 26 pseudoephedrine products to sign.
  1 27    d.  Require the purchaser to sign the electronic logbook.
  1 28 If the electronic logbook is not available, require a
  1 29 signature that is associated with a transaction number.
  1 30    e.  Enter the purchaser's name, address, date of purchase,
  1 31 time of purchase, name of the pseudoephedrine product
  1 32 purchased, and the quantity sold in the electronic logbook.
  1 33 If the electronic logbook is unavailable, an alternative
  1 34 record shall be kept that complies with rules adopted by the
  1 35 board.
  2  1    f.  Determine that the signature in the electronic logbook
  2  2 corresponds with the name on the driver's license or other
  2  3 state=issued photo identification card.
  2  4    g.  Provide notice that a purchaser entering a false
  2  5 statement or misrepresentation in the electronic logbook may
  2  6 subject the purchaser to criminal penalties under 18 U.S.C. }
  2  7 1001.
  2  8    h.  Keep electronic logbook records and any other records
  2  9 obtained if the electronic logbook is unavailable for
  2 10 twenty=four months from the date of the last entry.
  2 11    i.  Disclose electronic logbook information and any other
  2 12 associated records as provided by state and federal law.
  2 13    j.  Comply with training requirements pursuant to federal
  2 14 law.
  2 15    2.  This section is not applicable until such time as the
  2 16 board establishes the statewide real=time central repository.
  2 17 However, subsection 1, paragraph "h" is applicable upon the
  2 18 effective date of this Act.
  2 19    Sec. 3.  NEW SECTION.  124.212B  PSEUDOEPHEDRINE SALES ==
  2 20 TRACKING == PENALTY == CONTINGENT APPLICABILITY.
  2 21    1.  The board shall establish a real=time electronic
  2 22 repository to monitor the sale of schedule V products
  2 23 containing any detectible amount of pseudoephedrine, its
  2 24 salts, or optical isomers, or salts of optical isomers;
  2 25 ephedrine; or phenylpropanolamine.  A pharmacy dispensing such
  2 26 products shall report all such sales electronically to a
  2 27 central repository under the control of the board.
  2 28    2.  The information collected in the central repository is
  2 29 confidential unless otherwise ordered by a court, or released
  2 30 by the lawful custodian of the records pursuant to this
  2 31 section.
  2 32    3.  The information collected in the central repository
  2 33 shall be disclosed at the discretion of the executive
  2 34 secretary or director of the board or as otherwise provided by
  2 35 state or federal law.
  3  1    4.  A pharmacy, an employee of a pharmacy, or a licensed
  3  2 pharmacist shall not be provided access to the stored
  3  3 information in the electronic central repository and shall not
  3  4 be given the obligation or duty to view the stored
  3  5 information.
  3  6    5.  A pharmacy, or an employee of a pharmacy, or a licensed
  3  7 pharmacist shall not be given the obligation or duty to seek
  3  8 information from the central repository if the real=time
  3  9 electronic logbook becomes unavailable for use.
  3 10    6.  A pharmacy, or an employee of a pharmacy, or a licensed
  3 11 pharmacist shall not be liable to any person for any claim
  3 12 which may arise when reporting sales of products enumerated in
  3 13 subsection 1 to the central repository.
  3 14    7.  A person who discloses information stored in the
  3 15 central repository in violation of this section commits a
  3 16 simple misdemeanor.
  3 17    8.  The board shall adopt rules to administer this section.
  3 18    9.  This section is not applicable until such time as the
  3 19 board establishes the statewide real=time central repository.
  3 20    Sec. 4.  Section 124.213, Code 2007, is amended by striking
  3 21 the section and inserting in lieu thereof the following:
  3 22    124.213  PSEUDOEPHEDRINE PURCHASE RESTRICTIONS FROM
  3 23 PHARMACY OR RETAILER == PENALTY.
  3 24    1.  A person shall not purchase more than three thousand
  3 25 six hundred milligrams of pseudoephedrine, either separately
  3 26 or collectively, within a twenty=four=hour period from a
  3 27 pharmacy, or more than one package of a product containing
  3 28 pseudoephedrine within a twenty=four hour period from a
  3 29 retailer in violation of section 126.23A.
  3 30    2.  A person shall not purchase more than seven thousand
  3 31 five hundred milligrams of pseudoephedrine, either separately
  3 32 or collectively, within a thirty=day period from a pharmacy or
  3 33 from a retailer in violation of section 126.23A.
  3 34    3.  A person who violates this section commits a serious
  3 35 misdemeanor.
  4  1    Sec. 5.  Section 126.23A, subsection 1, paragraph a,
  4  2 subparagraph (1), Code 2007, is amended by striking the
  4  3 subparagraph and inserting in lieu thereof the following:
  4  4    (1)  Sell more than seven thousand five hundred milligrams
  4  5 of pseudoephedrine to the same person within a thirty=day
  4  6 period.
  4  7    Sec. 6.  Section 126.23A, subsection 1, paragraph b, Code
  4  8 2007, is amended to read as follows:
  4  9    b.  A retailer or an employee of a retailer shall do the
  4 10 following:
  4 11    (1)  Provide for the sale of a pseudoephedrine product in a
  4 12 locked cabinet or behind a sales counter where the public is
  4 13 unable to reach the product and where the public is not
  4 14 permitted.
  4 15    (2)  Require a purchaser to present a government=issued
  4 16 photo driver's license or other state=issued photo
  4 17 identification card identifying the purchaser prior to
  4 18 purchasing a pseudoephedrine product.
  4 19    (3)  Require the purchaser to sign a logbook and to also
  4 20 require the purchaser to legibly print the purchaser's name
  4 21 and address in the logbook.
  4 22    (4)  Print the name of the pseudoephedrine product
  4 23 purchased and quantity sold next to the name of each purchaser
  4 24 in the logbook.
  4 25    (4)  (5)  Determine the signature in the logbook
  4 26 corresponds with the name on the government=issued photo
  4 27 driver's license or other state=issued photo identification
  4 28 card.
  4 29    (5)  (6)  Keep the logbook twelve twenty=four months from
  4 30 the date of the last entry.
  4 31    (6)  (7)  Provide notification in a clear and conspicuous
  4 32 manner in a location where a pseudoephedrine product is
  4 33 offered for sale stating the following:
  4 34    Iowa law prohibits the over=the=counter purchase of more
  4 35 than one package of a product containing pseudoephedrine in a
  5  1 twenty=four=hour period or of more than seven thousand five
  5  2 hundred milligrams of pseudoephedrine within a thirty=day
  5  3 period.  If you purchase a product containing pseudoephedrine,
  5  4 you are required to sign a logbook which may be accessible to
  5  5 law enforcement officers.
  5  6    (8)  Provide notification affixed to the logbook stating
  5  7 that a purchaser entering a false statement or
  5  8 misrepresentation in the logbook may subject the purchaser to
  5  9 criminal penalties under 18 U.S.C. } 1001.
  5 10    (9)  Disclose logbook information as provided by state and
  5 11 federal law.
  5 12    (10)  Comply with training requirements pursuant to federal
  5 13 law.
  5 14    Sec. 7.  CONTINGENT APPLICABILITY == PHARMACY BOARD AND
  5 15 CODE EDITOR RESPONSIBILITIES.
  5 16    1.  The board of pharmacy examiners shall notify the Code
  5 17 editor when the establishment of the repository on a statewide
  5 18 basis is complete.
  5 19    2.  When the establishment of the central repository on a
  5 20 statewide basis is complete, the Code editor is directed to
  5 21 remove section 124.212A, subsection 2, and section 124.212B,
  5 22 subsection 9, from the Code and to internally renumber the
  5 23 sections as necessary.
  5 24                           EXPLANATION
  5 25    This bill relates to the sale of a pseudoephedrine product
  5 26 by pharmacy or retailer.
  5 27    PENALTIES.  The bill provides that a person shall not
  5 28 purchase more than 3,600 milligrams of pseudoephedrine, either
  5 29 collectively or separately, within a 24=hour period from a
  5 30 pharmacy unless the person has a prescription.  A person who
  5 31 violates this provision of the bill commits a serious
  5 32 misdemeanor.  Under current law and the bill, a person commits
  5 33 a serious misdemeanor if the person purchases more than 7,500
  5 34 milligrams of pseudoephedrine within a 30=day period from a
  5 35 pharmacy or retailer.
  6  1    PHARMACY.  The bill requires a purchaser of a
  6  2 pseudoephedrine product from a pharmacy to present a driver's
  6  3 license or other state=issued photo identification card prior
  6  4 to purchase, and sign an electronic logbook.  Current law does
  6  5 not require an electronic logbook and requires a purchaser to
  6  6 present a government=issued photo identification card prior to
  6  7 purchase.  The bill also provides that if the electronic
  6  8 logbook is unavailable, the pharmacy is required to keep an
  6  9 alternative record that complies with rules adopted by the
  6 10 state board of pharmacy examiners.
  6 11    The bill requires a pharmacy, an employee of a pharmacy, or
  6 12 a licensed pharmacist, to enter a purchaser's name, address,
  6 13 date of purchase, time of purchase, name of pseudoephedrine
  6 14 product, and quantity sold into an electronic logbook.
  6 15    The bill requires a pharmacy to keep electronic logbook
  6 16 records for a period of 24 months from the date of the last
  6 17 entry.  Current law requires the pharmacy to keep the logbook
  6 18 12 months from the date of the last entry.
  6 19    The bill provides that the state board of pharmacy
  6 20 examiners shall implement a statewide real=time central
  6 21 repository to track pseudoephedrine product sales at
  6 22 pharmacies.  The bill requires a pharmacy dispensing
  6 23 pseudoephedrine products to report all such sales
  6 24 electronically to the central repository under the control of
  6 25 the state board of pharmacy examiners.
  6 26    The bill makes confidential the information collected in
  6 27 the central repository unless otherwise ordered by a court, or
  6 28 lawfully released at the discretion of the executive secretary
  6 29 or director of the state board of pharmacy examiners.
  6 30    The bill provides that a pharmacy, an employee of a
  6 31 pharmacy, or a licensed pharmacist shall not be liable to any
  6 32 person for any claim which may arise when reporting
  6 33 pseudoephedrine sales to the central repository.
  6 34    The bill also requires a pharmacy to comply with training
  6 35 requirements pursuant to federal law.
  7  1    A person who discloses information stored in the central
  7  2 repository in violation of the bill commits a simple
  7  3 misdemeanor.
  7  4    RETAILER.  The bill requires a purchaser of a
  7  5 pseudoephedrine product from a retailer to present a driver's
  7  6 license or other state=issued photo identification card prior
  7  7 to purchase.  Current law requires a purchaser to present a
  7  8 government=issued photo identification card prior to purchase.
  7  9    The bill requires a retailer or an employee of a retailer
  7 10 to print the name of the pseudoephedrine product purchased and
  7 11 the quantity sold next to the name of each purchaser in the
  7 12 logbook.
  7 13    The bill requires the retailer to keep the logbook 24
  7 14 months from the date of the last entry.  Current law requires
  7 15 the retailer to keep the logbook 12 months from the date of
  7 16 the last entry.  The bill does not require a retailer to keep
  7 17 an electronic logbook of pseudoephedrine purchases.
  7 18    The bill also requires a retailer to comply with training
  7 19 requirements pursuant to federal law.
  7 20    CONTINGENT APPLICABILITY.  New Code sections 124.212A and
  7 21 124.212B created in the bill do not become applicable until
  7 22 the central repository under the control of the state board of
  7 23 pharmacy examiners is established on a statewide basis.
  7 24 However, Code section 124.212A, subsection 1, paragraph "h",
  7 25 in the bill, which requires a pharmacy to keep logbook records
  7 26 24 months from the date of the last entry, is applicable upon
  7 27 the effective date of the bill.
  7 28 LSB 1286DP 82
  7 29 jm:rj/gg/14.1